Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace

Liquid biopsy PD-L1 test, 8/16

August 2016—Biocept launched its CLIA-validated PD-L1 protein expression test, which uses Biocept’s proprietary, patented Target Selector platform with circulating tumor cells from a patient’s blood sample and can be used to detect and monitor PD-L1 protein expression throughout the course of a patient’s cancer therapy.

FISH slide hybridizer, 8/16

August 2016—Boekel Scientific introduced its RapidFISH slide hybridizer designed to simplify fluorescence in situ hybridization procedures for formalin-fixed, paraffin-embedded tissue samples, cell suspensions, and other tissue preparation procedures. The RapidFISH has a self-clamping slide tray design that maintains the required humidity and has an easy-to-use control system for temperature, time, and controlled temperature steps.

Gross room lab tray, 8/16

August 2016—Safety-Spec, a pathologist-owned company, has announced that the Gross Room Lab Tray is available for order on its website, Safety-Spec.com. Designed by a pathologist and laboratory scientist, the tray provides improved specimen organization in the gross room queue, resulting in increased efficiency and patient safety by reducing the potential for misidentification of specimens from a patient (intra-accession mislabeling) as well as misidentification between patients (inter-accession mislabeling).

Studies cite utility of molecular cancer classification test, 8/16

August 2016—A study published in Oncotarget (Brachtel EF, et al. Epub ahead of print March 28, 2016) demonstrates the high accuracy and success rate of Biotheranostics’ CancerType ID molecular cancer classifier in the diagnosis of cancer for specimens with limited tissue. Results from the study support additional clinical utility for CancerType ID in small biopsy and cytology cases.

D-dimer test kit, 8/16

August 2016—LGC Maine Standards announced its Validate D-Dimer calibration verification/linearity test kit has received 510(k) clearance for use on Instrumentation Laboratory’s ACL TOP hemostasis test systems. The kit evaluates D-dimer in a human-plasma base matrix, is prepared using the CLSI recommended “equal delta” method for linearity testing, and is liquid, ready to use.

SeraCare and NIST partner, 8/16

August 2016—SeraCare Life Sciences and the U.S. Department of Commerce National Institute of Standards and Technology have signed a three-year cooperative research and development agreement (CRADA) to advance the development of circulating tumor DNA diagnostic assay reference standard materials.

CE mark for molecular Dx system, 8/16

August 2016—GenMark Diagnostics received the CE mark for its ePlex Instrument System and ePlex Respiratory Pathogen (RP) Panel. The panel detects 20 viral and three bacterial targets in nasopharyngeal specimens.

Qiagen collaborations, 8/16

August 2016—Qiagen has entered into a licensing and co-development agreement with Munich-based Therawis Diagnostics to develop and commercialize predictive assays in oncology. An initial project will be to develop and market PITX2 as a marker to predict the effectiveness of anthracycline treatment in triple-negative and other high-risk breast cancer patients.

Cryostat, 8/16

August 2016—The Tissue-Tek Cryo3 Flex Cryostat, from Sakura Finetek USA, produces sections from 1 to 99 µm using a temperature-controlled blade holder and a 3-D precision chuck to accurately align the block face to the blade, reducing user’s trimming time and preserving specimens.